Caption Management’s Novavax NVAX Stock Holding History

Caption Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.66M	Sell	450,000 -36,800	-8%	-$334K	0.02%	624
2025 Q4	$3.27M	Buy	+486,800	New	+$3.67M	0.02%	655
2025 Q3	–	Sell	-100,000	Closed	-$630K	–	1937
2025 Q2	$630K	Hold	100,000	–	–	0.01%	1055
2025 Q1	$641K	Buy	+100,000	New	+$827K	0.01%	1034
2024 Q3	–	Sell	-100,000	Closed	-$1.27M	–	1499
2024 Q2	$1.27M	Sell	100,000 -154,000	-61%	-$1.55M	0.02%	605
2024 Q1	$1.21M	Buy	+254,000	New	+$1.18M	0.02%	683

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's NVAX Position: Q1 2026 in Review

Caption Management increased its Novavax (NVAX) stake by 6.5% in Q1 2026, buying an estimated $82.5K and bringing the position to 148,155 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #960.

Caption Management first reported a position in NVAX in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Caption Management held 148,155 shares of Novavax worth $1.21M as of Q1 2026.
Caption Management bought 9,105 Novavax shares in Q1 2026, an estimated $82.5K.
Novavax made up 0.01% of Caption Management's portfolio in Q1 2026, its #960 holding.
Caption Management first reported a position in Novavax in Q4 2018 and has held it in 7 quarters since.
Caption Management's Novavax position peaked at $1.4M in Q1 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.